Tonix Pharmaceuticals Holding Corp (TNXP) At $0.16 Offering A Unique Opportunity

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 2.18M but it saw 1413034 shares traded in last market. With a market cap of 13.26M USD, the company’s current market price of $0.16 came falling about -1.51 while comparing to the previous closing price of $0.16. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.31 and as low as $0.12.

Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $0.2148, while its current price level is -95.26% below from 52-week high level whereas it is 30.62% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2987 while that of 200 days or SMA-200 reads an average of $0.6251. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.19% during that period while stretching the period over a month that increases to 15.42%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.57 which implies that the stock is in oversold territory.

ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.

Over the week, TNXP’s stock price is moving -7.65% down while it is -54.79% when we observe its performance for the past one month. Year-to-date it is -61.04% down and over the past year, the stock is showing a downside performance of -95.10%.

Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 84.49M. Company’s return on investment (ROI) stands at -103.50% and return on equity (ROE) at -74.61%. Stock’s beta reads 2.20. Stock has a price to book (P/B) ratio of 0.09 while price to sale or P/S ratio amounts to 1.71. Its return on asset (ROA) is -61.38% on average.